跳至主要内容
临床试验/ISRCTN13097622
ISRCTN13097622已完成未知

Influence of the VitaBreath device on exercise tolerance in patients with chronic obstructive pulmonary disease

Philips0 个研究点目标入组 24 人开始时间: 2017年3月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
Philips
入组人数
24

研究概览

简要总结

2019 results in https://pubmed.ncbi.nlm.nih.gov/30650617/ (added 26/08/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female aged 40 years or older
  • 2. Current or previous smoking history, 10 or more pack years
  • 3. Spirometry confirmed stable COPD (GOLD stages II-IV) under optimal medical therapy
  • 4. Exhibit substantial exercise-induced dynamic hyperinflation (?IC baseline > 0,2 L)

排除标准

  • 1. Orthopaedic, neurological or other concomitant diseases that significantly impair normal biomechanical movement patterns, as judged by the investigator
  • 2. Moderate or severe COPD exacerbation within 6 weeks
  • 3. Unstable cardiac arrhythmia
  • 4. Unstable ischaemic heart disease, including myocardial infarction within 6 weeks
  • 5. Moderate or severe aortic stenosis or hypertrophic obstructive cardiomyopathy
  • 6. Uncontrolled hypertension
  • 7. Uncontrolled hypotension (SBP<85mmHg)
  • 8. Uncontrolled diabetes
  • 9. Intolerance of the VitaBreath device

研究者

发起方
Philips

相似试验

Influence of the Vitabreath on exercise tolerance in... | 临床试验